| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts accepted for publication only
|
|
|
2011
|
|
S4 |
p. S669-S834
166 p.
|
artikel
|
| 2 |
Abstracts accepted for publication only
|
|
|
2009
|
|
S4 |
p. S613-S677
65 p.
|
artikel
|
| 3 |
A comparative study of the in vitro activity of meropenem and representatives of the major classes of broad-spectrum antibiotics
|
Greenhalgh, J. Moira
|
|
1997
|
|
S4 |
p. 4S20-4S31
nvt p.
|
artikel
|
| 4 |
A compilation of studies assessing the in vitro activity of meropenem and comparators in 84 laboratories throughout Europe
|
Turner, Philip J.
|
|
1997
|
|
S4 |
p. 4S32-4S50
nvt p.
|
artikel
|
| 5 |
Addendum
|
|
|
2005
|
|
S4 |
p. 65-68
4 p.
|
artikel
|
| 6 |
Amphotericin B lipid preparations: what are the differences?
|
Adler-Moore, J.P.
|
|
2008
|
|
S4 |
p. 25-36
12 p.
|
artikel
|
| 7 |
A multinational workshop on drug-resistant pathogens of the respiratory tract: prevalence, risk factors and intervention strategies
|
Tomasz, Alexander
|
|
1999
|
|
S4 |
p. 4S1-4S2
nvt p.
|
artikel
|
| 8 |
Antibacterial drug discovery in the 21st century
|
Bush, K
|
|
2004
|
|
S4 |
p. 10-17
8 p.
|
artikel
|
| 9 |
Antibacterial drug discovery: is it all downhill from here?
|
Projan, S.J.
|
|
2004
|
|
S4 |
p. 18-22
5 p.
|
artikel
|
| 10 |
Antibacterial drug discovery: is small pharma the solution?
|
Boggs, A.F.
|
|
2004
|
|
S4 |
p. 32-36
5 p.
|
artikel
|
| 11 |
Antibiotic usage and the incidence of resistance
|
Huovinen, Pentii
|
|
1999
|
|
S4 |
p. 4S12-4S16
nvt p.
|
artikel
|
| 12 |
Antibiotic use and pneumococcal resistance to penicillin: the French experience
|
Guillemot, Didier
|
|
1999
|
|
S4 |
p. 4S38-4S42
nvt p.
|
artikel
|
| 13 |
Antimicrobial drug development – the past, the present, and the future
|
Powers, J.H.
|
|
2004
|
|
S4 |
p. 23-31
9 p.
|
artikel
|
| 14 |
Antimicrobial therapy of infections with aerobic Gram-positive rods
|
von Graevenitz, A.
|
|
2001
|
|
S4 |
p. 43-46
4 p.
|
artikel
|
| 15 |
A perspective on liposomal amphotericin B (AmBisome®)
|
Richardson, M.
|
|
2008
|
|
S4 |
p. 1-4
4 p.
|
artikel
|
| 16 |
Author Index
|
|
|
2009
|
|
S4 |
p. S679-S725
47 p.
|
artikel
|
| 17 |
Author Index
|
|
|
2011
|
|
S4 |
p. S835-S895
61 p.
|
artikel
|
| 18 |
Author index
|
|
|
2006
|
|
S4 |
p. S768-S794
27 p.
|
artikel
|
| 19 |
Carriage and antibiotic resistance of respiratory pathogens and molecular epidemiology of antibiotic-resistant Streptococcus pneumoniae colonizing children in day-care centers in Lisbon: the Portuguese day-care center initiative
|
Lencastre, Herminia de
|
|
1999
|
|
S4 |
p. 4S55-4S63
nvt p.
|
artikel
|
| 20 |
Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage
|
Dagan, Ron
|
|
1999
|
|
S4 |
p. 4S29-4S37
nvt p.
|
artikel
|
| 21 |
Changes in the intestinal microbiota from adulthood through to old age
|
O'Toole, P.W.
|
|
2012
|
|
S4 |
p. 44-46
3 p.
|
artikel
|
| 22 |
Changing epidemiology of systemic fungal infections
|
Richardson, M.
|
|
2008
|
|
S4 |
p. 5-24
20 p.
|
artikel
|
| 23 |
Clinical manifestations, treatment and control of infections caused by Clostridium difficile
|
Bouza, E.
|
|
2005
|
|
S4 |
p. 57-64
8 p.
|
artikel
|
| 24 |
Coagulase-negative staphylococci as a cause of infections related to intravascular prosthetic devices: limitations of present therapy
|
Schulin, T.
|
|
2001
|
|
S4 |
p. 1-7
7 p.
|
artikel
|
| 25 |
Combination antifungal therapy: a critical review of the evidence
|
Ostrosky-Zeichner, L.
|
|
2008
|
|
S4 |
p. 65-70
6 p.
|
artikel
|
| 26 |
Common therapeutic approaches for the control of oral biofilms: microbiological safety and efficacy
|
Gilbert, P.
|
|
2007
|
|
S4 |
p. 17-24
8 p.
|
artikel
|
| 27 |
Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients
|
Einsele, H.
|
|
2008
|
|
S4 |
p. 37-45
9 p.
|
artikel
|
| 28 |
Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue
|
Cani, P.D.
|
|
2012
|
|
S4 |
p. 50-53
4 p.
|
artikel
|
| 29 |
Development and testing of Streptococcus pneumoniae conjugate vaccines
|
Klein, David L.
|
|
1999
|
|
S4 |
p. 4S17-4S28
nvt p.
|
artikel
|
| 30 |
Diagnosis of Chlamydia pneumoniae
|
Saikku, Pekka
|
|
1998
|
|
S4 |
p. 4S7-4S13
nvt p.
|
artikel
|
| 31 |
Discussion and Conclusion
|
|
|
1998
|
|
S4 |
p. 4S37-4S39
nvt p.
|
artikel
|
| 32 |
Editorial
|
Raoult, D.
|
|
2012
|
|
S4 |
p. 1-
1 p.
|
artikel
|
| 33 |
Elucidating metabolic pathways and digging for genes of unknown function in microbial communities: the riboswitch approach
|
Gutiérrez-Preciado, A.
|
|
2012
|
|
S4 |
p. 35-39
5 p.
|
artikel
|
| 34 |
Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy
|
Blijlevens, N.M.A.
|
|
2001
|
|
S4 |
p. 47-52
6 p.
|
artikel
|
| 35 |
Epidemiology of Chlamydia pneumoniae
|
Blasi, F.
|
|
1998
|
|
S4 |
p. 4S1-4S6
nvt p.
|
artikel
|
| 36 |
Erratum to Clinical Microbiology and Infection, Vol. 12, Suppl. 4
|
|
|
2006
|
|
S4 |
p. S806-
1 p.
|
artikel
|
| 37 |
European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid
|
Bassetti, M.
|
|
2014
|
|
S4 |
p. 3-18
16 p.
|
artikel
|
| 38 |
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid
|
Chastre, J.
|
|
2014
|
|
S4 |
p. 19-36
18 p.
|
artikel
|
| 39 |
European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection
|
Crobach, M.J.T.
|
|
2016
|
|
S4 |
p. S63-S81
19 p.
|
artikel
|
| 40 |
Evolution of genetic diversity using networks: the human gut microbiome as a case study
|
Bapteste, E.
|
|
2012
|
|
S4 |
p. 40-43
4 p.
|
artikel
|
| 41 |
Foreword
|
Nord, Carl.Erik
|
|
2004
|
|
S4 |
p. III-
1 p.
|
artikel
|
| 42 |
Foreword
|
Nord, C.E.
|
|
2005
|
|
S4 |
p. iii-
1 p.
|
artikel
|
| 43 |
Good oral health is essential for good general health: the oral–systemic connection
|
Seymour, G.J.
|
|
2007
|
|
S4 |
p. 1-2
2 p.
|
artikel
|
| 44 |
Gut microbiota correlates with energy gain from dietary fibre and appears to be associated with acute and chronic intestinal diseases
|
Ukhanova, M.
|
|
2012
|
|
S4 |
p. 62-66
5 p.
|
artikel
|
| 45 |
Human infections caused by glycopeptide-resistant Enterococcus spp: are they a zoonosis?
|
Sundsfjord, A.
|
|
2001
|
|
S4 |
p. 16-33
18 p.
|
artikel
|
| 46 |
Human milk oligosaccharide consumption by intestinal microbiota
|
Marcobal, A.
|
|
2012
|
|
S4 |
p. 12-15
4 p.
|
artikel
|
| 47 |
Identifying a healthy oral microbiome through metagenomics
|
Alcaraz, L.D.
|
|
2012
|
|
S4 |
p. 54-57
4 p.
|
artikel
|
| 48 |
Infections caused by Gram-positive bacteria: situation and challenges of treatment
|
Bouza, Emilio
|
|
2001
|
|
S4 |
p. iii-
1 p.
|
artikel
|
| 49 |
Introduction
|
Saikku, Pekka
|
|
1998
|
|
S4 |
p. i-
1 p.
|
artikel
|
| 50 |
Introduction: infections caused by emerging resistant pathogens
|
Bouza, E.
|
|
2005
|
|
S4 |
p. iv-
1 p.
|
artikel
|
| 51 |
Introductory remarks
|
Bush, K.
|
|
2004
|
|
S4 |
p. IV-
1 p.
|
artikel
|
| 52 |
Keyword index
|
|
|
2006
|
|
S4 |
p. S795-S806
12 p.
|
artikel
|
| 53 |
β-Lactamases: quality and resistance
|
Medeiros, Antone A.
|
|
1997
|
|
S4 |
p. 4S2-4S9
nvt p.
|
artikel
|
| 54 |
β-Lactamases: quantity and resistance
|
Livermore, David M.
|
|
1997
|
|
S4 |
p. 4S10-4S19
nvt p.
|
artikel
|
| 55 |
Late Breaking News
|
|
|
2011
|
|
S4 |
p. A1-A4
nvt p.
|
artikel
|
| 56 |
Limitations of presently available glycopeptides in the treatment of Gram-positive infection
|
Ziglam, H.M.
|
|
2001
|
|
S4 |
p. 53-65
13 p.
|
artikel
|
| 57 |
Linezolid: pharmacokinetic characteristics and clinical studies
|
Bouza, E.
|
|
2001
|
|
S4 |
p. 75-82
8 p.
|
artikel
|
| 58 |
Link between intracellular pathogens and cardiovascular diseases
|
Gurfinkel, Enrique
|
|
1998
|
|
S4 |
p. 4S33-4S36
nvt p.
|
artikel
|
| 59 |
Liposomal amphotericin B: what is its role in 2008?
|
Lanternier, F.
|
|
2008
|
|
S4 |
p. 71-83
13 p.
|
artikel
|
| 60 |
Meropenem: laboratory and clinical data
|
Drusano, George
|
|
1997
|
|
S4 |
p. 4S51-4S59
nvt p.
|
artikel
|
| 61 |
Metagenomic epidemiology: a public health need for the control of antimicrobial resistance
|
Baquero, F.
|
|
2012
|
|
S4 |
p. 67-73
7 p.
|
artikel
|
| 62 |
Metagenomics and antibiotics
|
Garmendia, L.
|
|
2012
|
|
S4 |
p. 27-31
5 p.
|
artikel
|
| 63 |
Metagenomics and development of the gut microbiota in infants
|
Valles, Y.
|
|
2012
|
|
S4 |
p. 21-26
6 p.
|
artikel
|
| 64 |
Metagenomics and probiotics
|
Gueimonde, M.
|
|
2012
|
|
S4 |
p. 32-34
3 p.
|
artikel
|
| 65 |
Metagenomics of human microbiome: beyond 16s rDNA
|
Gosalbes, M.J.
|
|
2012
|
|
S4 |
p. 47-49
3 p.
|
artikel
|
| 66 |
Metamobilomics – expanding our knowledge on the pool of plasmid encoded traits in natural environments using high-throughput sequencing
|
Li, L.L.
|
|
2012
|
|
S4 |
p. 8-11
4 p.
|
artikel
|
| 67 |
Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy
|
Cunha, B.A.
|
|
2005
|
|
S4 |
p. 33-42
10 p.
|
artikel
|
| 68 |
Modification of prescribers’ behavior: the Icelandic approach
|
Kristinsson, Karl G.
|
|
1999
|
|
S4 |
p. 4S43-4S47
nvt p.
|
artikel
|
| 69 |
Multidrug resistance in Gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs)
|
Giamarellou, H.
|
|
2005
|
|
S4 |
p. 1-16
16 p.
|
artikel
|
| 70 |
New dosing strategies for liposomal amphotericin B in high-risk patients
|
Ellis, Michael
|
|
2008
|
|
S4 |
p. 55-64
10 p.
|
artikel
|
| 71 |
New options for treatment of candidaemia in critically ill patients
|
Ruhnke, M.
|
|
2008
|
|
S4 |
p. 46-54
9 p.
|
artikel
|
| 72 |
Nonantibibiotic measures for the prevention of Gram-positive infections
|
Eggimann, P.
|
|
2001
|
|
S4 |
p. 91-99
9 p.
|
artikel
|
| 73 |
Oral presentations
|
|
|
2009
|
|
S4 |
p. S1-S106
106 p.
|
artikel
|
| 74 |
Oral presentations
|
|
|
2011
|
|
S4 |
p. S1-S107
107 p.
|
artikel
|
| 75 |
Posters
|
|
|
2011
|
|
S4 |
p. S108-S668
561 p.
|
artikel
|
| 76 |
Posters
|
|
|
2009
|
|
S4 |
p. S107-S612
506 p.
|
artikel
|
| 77 |
P441 – P678
|
|
|
2006
|
|
S4 |
p. S111-S198
88 p.
|
artikel
|
| 78 |
P679 – P940
|
|
|
2006
|
|
S4 |
p. S199-S291
93 p.
|
artikel
|
| 79 |
P1198 – P1459
|
|
|
2006
|
|
S4 |
p. S384-S480
97 p.
|
artikel
|
| 80 |
P1460 – P1884
|
|
|
2006
|
|
S4 |
p. S481-S634
154 p.
|
artikel
|
| 81 |
P941 – P1197
|
|
|
2006
|
|
S4 |
p. S292-S383
92 p.
|
artikel
|
| 82 |
Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolemic mice
|
Campbell, L.A.
|
|
1998
|
|
S4 |
p. 4S23-4S32
nvt p.
|
artikel
|
| 83 |
Preface
|
Phillips, Ian
|
|
1997
|
|
S4 |
p. 4S1-
1 p.
|
artikel
|
| 84 |
Relationship between periodontal infections and systemic disease
|
Seymour, G.J.
|
|
2007
|
|
S4 |
p. 3-10
8 p.
|
artikel
|
| 85 |
Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection
|
Carratalà, J.
|
|
2001
|
|
S4 |
p. 83-90
8 p.
|
artikel
|
| 86 |
Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model
|
Ekdahl, Karl
|
|
1999
|
|
S4 |
p. 4S48-4S54
nvt p.
|
artikel
|
| 87 |
Role of intracellular pathogens in respiratory tract infections
|
Mayaud, C.
|
|
1998
|
|
S4 |
p. 4S14-4S22
nvt p.
|
artikel
|
| 88 |
R1885 – R2270
|
|
|
2006
|
|
S4 |
p. S635-S767
133 p.
|
artikel
|
| 89 |
Spatial and temporal variability of the human microbiota
|
Parfrey, L.W.
|
|
2012
|
|
S4 |
p. 5-7
3 p.
|
artikel
|
| 90 |
S8 – S47 and O50 – O440
|
|
|
2006
|
|
S4 |
p. S1-S110
110 p.
|
artikel
|
| 91 |
Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains
|
Paradisi, J.
|
|
2001
|
|
S4 |
p. 34-42
9 p.
|
artikel
|
| 92 |
Tetracycline resistance genes and mobile genetic elements from the oral metagenome
|
Mullany, P.
|
|
2012
|
|
S4 |
p. 58-61
4 p.
|
artikel
|
| 93 |
The adult intestinal core microbiota is determined by analysis depth and health status
|
Salonen, A.
|
|
2012
|
|
S4 |
p. 16-20
5 p.
|
artikel
|
| 94 |
The challenge of multiresistant Streptococcus pneumoniae: international initiatives in day-care centers and the use of molecular epidemiologic techniques
|
Tomasz, Alexander
|
|
1999
|
|
S4 |
p. 4S64-4S68
nvt p.
|
artikel
|
| 95 |
The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health
|
Davies, R.M.
|
|
2007
|
|
S4 |
p. 25-29
5 p.
|
artikel
|
| 96 |
The interface between oral and systemic health: the need for more collaboration
|
Migliorati, C.A.
|
|
2007
|
|
S4 |
p. 11-16
6 p.
|
artikel
|
| 97 |
The microbiome as a human organ
|
Baquero, F.
|
|
2012
|
|
S4 |
p. 2-4
3 p.
|
artikel
|
| 98 |
The need for new antibiotics
|
Livermore, D.M.
|
|
2004
|
|
S4 |
p. 1-9
9 p.
|
artikel
|
| 99 |
The oxazolidinones as a new family of antimicrobial agent
|
Marchese, A.
|
|
2001
|
|
S4 |
p. 66-74
9 p.
|
artikel
|
| 100 |
Therapy of sepsis
|
Young, Lowell S.
|
|
1997
|
|
S4 |
p. 4S60-4S65
nvt p.
|
artikel
|
| 101 |
The VISA/GISA problem: therapeutic implications
|
Liñares, J.
|
|
2001
|
|
S4 |
p. 8-15
8 p.
|
artikel
|
| 102 |
Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa
|
Rossolini, G.M.
|
|
2005
|
|
S4 |
p. 17-32
16 p.
|
artikel
|
| 103 |
Treatment options for resistant pneumococcal infections
|
Pallares, Roman
|
|
1999
|
|
S4 |
p. 4S3-4S11
nvt p.
|
artikel
|
| 104 |
Vancomycin-resistant enterococci: consequences for therapy and infection control
|
Mascini, E.M.
|
|
2005
|
|
S4 |
p. 43-56
14 p.
|
artikel
|
| 105 |
What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe?
|
Dumitrescu, O.
|
|
2014
|
|
S4 |
p. 1-2
2 p.
|
artikel
|
Tijdschrift beschrijving